Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalBone Marrow TransplantationCombined Modality TherapyGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMultiple MyelomaMyeloablative AgonistsTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesHematopoiesisAmyloidosisLeukemiaSalvage TherapyIfosfamideSurvival RateVincristineSurvival AnalysisBlood CellsCarmustineGraft vs Leukemia EffectCytarabineHodgkin DiseaseBone and BonesTime FactorsLeukemia, Myeloid, AcutePlatelet CountBone MarrowMyelodysplastic SyndromesAnemia, AplasticCytomegalovirus InfectionsBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionNeoplasmsFatal OutcomeFollow-Up StudiesFeasibility StudiesHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaDoxorubicinCyclosporineHLA AntigensBlood DonorsImmunophenotypingBone Marrow CellsImmunosuppressionMesenchymal Stem Cell TransplantationProspective StudiesRecombinant ProteinsBone Marrow PurgingBone Marrow DiseasesLymphoma, T-CellPilot ProjectsPrednisoneCarboplatinAntigens, CDPrognosisAntineoplastic AgentsNeoplasm, Residual